Y08284
Y08284 is a potent and selective orally bioavailable CBP bromodomain inhibitor with an IC50 of 4.21 nM. It demonstrates anti-proliferative activity against prostate cancer cell lines such as LNCaP and shows anti-tumor effects in research models, supporting its use in oncology and epigenetic mechanism studies.
Product Specifications
CAS Number
2688745-47-1
Field of Research
Epigenetics & Chromatin
Smiles
C (NC1=C (F) C (=CC (C (C) O) =C1) C2=CN (N=C2) C3CC3) (=O) C4=C5N (C (C (C) =O) =C4) C=CC (OC) =C5
Molecular Formula
C26H25FN4O4
Molecular Weight
476.5
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7013085-01 0.02 mg
Recombinant Staphylococcus haemolyticus 4,4'-diaponeurosporenoate glycosyltransferase (crtQ)
Sign In for Pricing
View Details 
MBS7013085-02 0.1 mg
Recombinant Staphylococcus haemolyticus 4,4'-diaponeurosporenoate glycosyltransferase (crtQ)
Sign In for Pricing
View Details 
MBS7013085-03 5x 0.1 mg
Recombinant Staphylococcus haemolyticus 4,4'-diaponeurosporenoate glycosyltransferase (crtQ)
Sign In for Pricing
View Details